MTHFR and hyperhomocysteinemia: It was reported that a reduction in MTHFR (methylenetetrahydrofolate reductase) enzyme activity increased plasma homocysteine levels, indirectly contributing to the onset of CHDs, as hyperhomocysteinemia was positively associated with CHDs [76,77,78].